Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance (2024)

Abstract

Mutations in mexZ, encoding a negative regulator of theexpression of the mexXY efflux pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung infection. Although traditionally related to resistance to the first-line drug tobramycin, mexZ mutations are associated with low-level aminoglycoside resistance when determined in the laboratory, suggesting that their selection during infection may not be necessarily, or only, related to tobramycin therapy. Here, we show that mexZ-mutated bacteria tend to accumulate inside the epithelial barrier of a human airway infection model, thus colonising the epithelium while being protected against diverse antibiotics. This phenotype is mediated by overexpression of lecA, a quorum sensing-controlled gene, encoding a lectin involved in P. aeruginosa tissue invasiveness. We find that lecA overexpression is caused by a disrupted equilibrium between the overproduced MexXY and another efflux pump, MexAB, which extrudes quorum sensing signals. Our results indicate that mexZ mutations affect the expression of quorum sensing-regulated pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within patients, something unnoticeable using standard laboratory tests.

Original languageEnglish
Article number2584
JournalNature Communications
Volume15
Issue number1
ISSN2041-1723
DOIs
Publication statusPublished - 2024

Access to Document

  • FulltextFinal published version, 4.31 MB

OpenUrl availability

Full text

    Fingerprint

    Dive into the research topics of 'Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance'. Together they form a unique fingerprint.

    Cite this

    • APA
    • Author
    • BIBTEX
    • Harvard
    • Standard
    • RIS
    • Vancouver

    Laborda, P., Lolle, S., Hernando-Amado, S., Alcalde-Rico, M., Aanæs, K., Martínez, J. L., Molin, S. (2024). Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance. Nature Communications, 15(1), Article 2584. https://doi.org/10.1038/s41467-024-46938-w

    Laborda, Pablo ; Lolle, Signe ; Hernando-Amado, Sara et al. / Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance. In: Nature Communications. 2024 ; Vol. 15, No. 1.

    @article{ea957ca9e8d7477092a8ec3959f807dd,

    title = "Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance",

    abstract = "Mutations in mexZ, encoding a negative regulator of theexpression of the mexXY efflux pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung infection. Although traditionally related to resistance to the first-line drug tobramycin, mexZ mutations are associated with low-level aminoglycoside resistance when determined in the laboratory, suggesting that their selection during infection may not be necessarily, or only, related to tobramycin therapy. Here, we show that mexZ-mutated bacteria tend to accumulate inside the epithelial barrier of a human airway infection model, thus colonising the epithelium while being protected against diverse antibiotics. This phenotype is mediated by overexpression of lecA, a quorum sensing-controlled gene, encoding a lectin involved in P. aeruginosa tissue invasiveness. We find that lecA overexpression is caused by a disrupted equilibrium between the overproduced MexXY and another efflux pump, MexAB, which extrudes quorum sensing signals. Our results indicate that mexZ mutations affect the expression of quorum sensing-regulated pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within patients, something unnoticeable using standard laboratory tests.",

    author = "Pablo Laborda and Signe Lolle and Sara Hernando-Amado and Manuel Alcalde-Rico and Kasper Aan{\ae}s and Mart{\'i}nez, {Jos{\'e} Luis} and S{\o}ren Molin and Johansen, {Helle Krogh}",

    note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",

    year = "2024",

    doi = "10.1038/s41467-024-46938-w",

    language = "English",

    volume = "15",

    journal = "Nature Communications",

    issn = "2041-1723",

    publisher = "Nature Publishing Group",

    number = "1",

    }

    Laborda, P, Lolle, S, Hernando-Amado, S, Alcalde-Rico, M, Aanæs, K, Martínez, JL, Molin, S 2024, 'Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance', Nature Communications, vol. 15, no. 1, 2584. https://doi.org/10.1038/s41467-024-46938-w

    Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance. / Laborda, Pablo; Lolle, Signe; Hernando-Amado, Sara et al.
    In: Nature Communications, Vol. 15, No. 1, 2584, 2024.

    Research output: Contribution to journalJournal articleResearchpeer-review

    TY - JOUR

    T1 - Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance

    AU - Laborda, Pablo

    AU - Lolle, Signe

    AU - Hernando-Amado, Sara

    AU - Alcalde-Rico, Manuel

    AU - Aanæs, Kasper

    AU - Martínez, José Luis

    AU - Molin, Søren

    AU - Johansen, Helle Krogh

    N1 - Publisher Copyright:© The Author(s) 2024.

    PY - 2024

    Y1 - 2024

    N2 - Mutations in mexZ, encoding a negative regulator of theexpression of the mexXY efflux pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung infection. Although traditionally related to resistance to the first-line drug tobramycin, mexZ mutations are associated with low-level aminoglycoside resistance when determined in the laboratory, suggesting that their selection during infection may not be necessarily, or only, related to tobramycin therapy. Here, we show that mexZ-mutated bacteria tend to accumulate inside the epithelial barrier of a human airway infection model, thus colonising the epithelium while being protected against diverse antibiotics. This phenotype is mediated by overexpression of lecA, a quorum sensing-controlled gene, encoding a lectin involved in P. aeruginosa tissue invasiveness. We find that lecA overexpression is caused by a disrupted equilibrium between the overproduced MexXY and another efflux pump, MexAB, which extrudes quorum sensing signals. Our results indicate that mexZ mutations affect the expression of quorum sensing-regulated pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within patients, something unnoticeable using standard laboratory tests.

    AB - Mutations in mexZ, encoding a negative regulator of theexpression of the mexXY efflux pump genes, are frequently acquired by Pseudomonas aeruginosa at early stages of lung infection. Although traditionally related to resistance to the first-line drug tobramycin, mexZ mutations are associated with low-level aminoglycoside resistance when determined in the laboratory, suggesting that their selection during infection may not be necessarily, or only, related to tobramycin therapy. Here, we show that mexZ-mutated bacteria tend to accumulate inside the epithelial barrier of a human airway infection model, thus colonising the epithelium while being protected against diverse antibiotics. This phenotype is mediated by overexpression of lecA, a quorum sensing-controlled gene, encoding a lectin involved in P. aeruginosa tissue invasiveness. We find that lecA overexpression is caused by a disrupted equilibrium between the overproduced MexXY and another efflux pump, MexAB, which extrudes quorum sensing signals. Our results indicate that mexZ mutations affect the expression of quorum sensing-regulated pathways, thus promoting tissue invasiveness and protecting bacteria from the action of antibiotics within patients, something unnoticeable using standard laboratory tests.

    U2 - 10.1038/s41467-024-46938-w

    DO - 10.1038/s41467-024-46938-w

    M3 - Journal article

    C2 - 38519499

    AN - SCOPUS:85188426897

    SN - 2041-1723

    VL - 15

    JO - Nature Communications

    JF - Nature Communications

    IS - 1

    M1 - 2584

    ER -

    Laborda P, Lolle S, Hernando-Amado S, Alcalde-Rico M, Aanæs K, Martínez JL et al. Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance. Nature Communications. 2024;15(1):2584. doi: 10.1038/s41467-024-46938-w

    Mutations in the efflux pump regulator MexZ shift tissue colonization by Pseudomonas aeruginosa to a state of antibiotic tolerance (2024)

    FAQs

    How does an efflux pump cause antibiotic resistance? ›

    The activity of efflux pumps is one of the reasons for bacterial resistance to certain antibiotics and bactericides. This occurs when the substance structurally resembles the pump's natural substrate or when the selectivity of the pump is modest (multidrug resistance, MDR pumps).

    What is the role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm? ›

    Abstract. Efflux pumps are widely implicated in antibiotic resistance because they can extrude the majority of clinically relevant antibiotics from within cells to the extracellular environment. However, there is increasing evidence from many studies to suggest that the pumps also play a role in biofilm formation.

    What are the mechanisms of antibiotic resistance in Pseudomonas aeruginosa PA Lambert? ›

    There are three basic mechanisms by which organisms resist the action of antimicrobial agents: restricted uptake and efflux; drug inactivation and changes in targets. The contribution of each of these to the resistance of P.

    What are the efflux systems in Pseudomonas aeruginosa? ›

    aeruginosa, four efflux pumps have been described, MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY (17, 18, 32, 34). The genes encoding these pumps are arranged as operons, with the first gene encoding a membrane fusion protein that is associated with the cytoplasmic membrane (MexA, MexC, MexE, and MexX).

    How might efflux pumps increase antibiotic resistance in bacteria quizlet? ›

    How might efflux pumps increase antibiotic resistance in bacteria? Resistant bacteria may have a greater number of efflux pumps on their cell surfaces. Some bacteria can decrease the specificity of their efflux pumps, increasing the number of different antibiotics the pumps can eliminate.

    What is antibiotic resistance and how does antibiotic resistance occur? ›

    Antibiotic resistance occurs when bacteria evolve to evade the effect of antibiotics through multiple different mechanisms. Dissemination of antibiotic resistance genes is an ecological and public health concern. Certain bacteria are able to neutralize an antibiotic by altering its component to render it ineffective.

    What is the role of bacterial efflux pump proteins in antibiotic resistance across microbial species? ›

    Efflux pumps play a central role in making a bacterium resistant to multiple antibiotics due to their ability to expel a wide range of structurally diverse compounds.

    What happens when a bacteria develops a drug pump for resistance? ›

    Germs get rid of antibiotics using pumps in their cell walls to remove antibiotic drugs that enter the cell. Example: Some Pseudomonas aeruginosa bacteria can produce pumps to get rid of several different important antibiotic drugs, including fluoroquinolones, beta-lactams, chloramphenicol, and trimethoprim.

    How does efflux work in bacteria? ›

    Bacterial efflux describes a process where molecules are pumped from inside bacterial cells to outside. This is done by molecular machines called efflux pumps. These are found in the membrane of bacterial cells and they are very important because they contribute to antimicrobial resistance.

    Why is Pseudomonas so hard to treat? ›

    The infections are hard to treat because the bacteria can resist many types of antibiotics, the medicines normally used to kill bacteria.

    Why is Pseudomonas so resistant to antibiotics? ›

    Pseudomonas aeruginosa has been shown to possess a high level of intrinsic resistance to most antibiotics through restricted outer membrane permeability, efflux systems that pump antibiotics out of the cell and production of antibiotic-inactivating enzymes such as β-lactamases (Fig.

    How do you treat multidrug-resistant Pseudomonas? ›

    In patients hospitalized in settings where the local epidemiology suggests an MDR-PA rate lower than 25% and without risk factors for MDR-PA, treatment includes one antipseudomonal antibiotic, such as, in decreasing order of priority, carbapenem; piperacillin-tazobactam; cefepime; ceftazidime in cases of BSI, VAP, and ...

    Where does Pseudomonas aeruginosa colonize? ›

    P. aeruginosa most commonly exists in the environment, like in water, plants and soil. But it also appears in moist or wet areas, like bathtubs or sinks. You may also have it on your skin, but it may not cause an infection.

    What are 3 infections that are caused by the green bacteria Pseudomonas aeruginosa? ›

    The most serious infections include malignant external otitis, endophthalmitis, endocarditis, meningitis, pneumonia, and septicemia.

    What does Pseudomonas aeruginosa need to grow? ›

    The organism can utilize over 100 organic molecules as a source of carbon and/or energy and as a prototroph, generally has the ability to grow on a minimal salts growth medium with a single source of carbon and energy. P. aeruginosa grows well at 37 °C, but it can survive in broad temperatures ranging from 4–42 °C.

    How do efflux transporters affect the bioavailability of the drugs? ›

    Efflux Transporters in the Intestine

    In the intestine, drug-transporter interactions involving the efflux transporters often result in poor absorption and low oral bioavailability as the drug is readily effluxed back into the intestinal lumen and excreted out of the body.

    Why would an efflux pump for penicillin? ›

    Why would an efflux pump for penicillin located on a bacterial cell membrane not be effective at providing resistance to the drug? The efflux pumps would not stop penicillin from blocking metabolic pathways. There are fewer efflux pumps on the cell membrane. The cell membrane is the target of penicillin.

    Top Articles
    Latest Posts
    Article information

    Author: Catherine Tremblay

    Last Updated:

    Views: 5439

    Rating: 4.7 / 5 (67 voted)

    Reviews: 90% of readers found this page helpful

    Author information

    Name: Catherine Tremblay

    Birthday: 1999-09-23

    Address: Suite 461 73643 Sherril Loaf, Dickinsonland, AZ 47941-2379

    Phone: +2678139151039

    Job: International Administration Supervisor

    Hobby: Dowsing, Snowboarding, Rowing, Beekeeping, Calligraphy, Shooting, Air sports

    Introduction: My name is Catherine Tremblay, I am a precious, perfect, tasty, enthusiastic, inexpensive, vast, kind person who loves writing and wants to share my knowledge and understanding with you.